Modelling distinct modes of Tumour invasion and metastasis

Drug Discovery Today: Disease Models

Volumn 8, Issue 2-3, 2011, Pages 103-112

  Carragher, Neil O ^a   Frame, Margaret C ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INVASION; CANCER MODEL; CANCER MORTALITY; CANCER PATIENT; DRUG TARGETING; HUMAN; IMAGING SYSTEM; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; NONHUMAN; PROTEOMICS;

EID: 82455164318     PISSN: None     EISSN: 17406757     Source Type: Journal    
DOI: 10.1016/j.ddmod.2011.06.005     Document Type: Review

References (40)

1. Overall, C. M. and Kleifeld, O. (2006) Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and antitargets for cancer therapy. Nat. Rev. Cancer 6, 227-239 (Pubitemid 43292566)
2. Storr, S. J. et al. (2011) The calpain system and cancer. Nat. Rev. Cancer 11, 364-374
3. Brunton, V. G. and Frame, M. C. (2008) Src and focal adhesion kinase as therapeutic targets in cancer. Curr. Opin. Pharmacol. 8, 427-432
4. Gianelli, G. et al. (1997) Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 277, 225-228
5. Hassoun, A. T. et al. (2007) A rapid screening method for populationspecific neuronal motogens, substrates and associated signaling pathways. J. Neurosci. Methods 166, 178-194 (Pubitemid 350016397)
6. Yarrow, J. C. et al. (2004) A high-throughput cell migration assay using scratch wound healing, a comparison of image-based readout methods. BMC Biotechnol. 4, 21
7. Sameni, M. et al. (2009) Imaging and quantifying the dynamics of tumorassociated proteolysis. Clin. Exp. Metastasis 26, 299-309
8. Wolf, K. et al. (2007) Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nat. Cell Biol. 9, 893-904 (Pubitemid 47190444)
9. Carragher, N. O. (2009) Profiling distinct mechanisms of tumour invasion for drug discovery: imaging adhesion, signalling and matrix turnover. Clin. Exp. Metastasis 26, 381-397
10. Umezu-Goto, M. et al. (2002) Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J. Cell Biol. 158, 227-233
11. Zabel, B. A. et al. (2009) Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands. J. Immunol. 183, 3204-3211
12. Singh, S. et al. (2009) Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion. Cancer Lett. 283, 29-35
13. Gough, W. et al. (2011) A quantitative, facile, and high-throughput imagebased cell migration method is a robust alternative to the scratch assay. J. Biomol. Screen 16, 155-163
14. McGee, J. et al. (2011) Product focus: screening robotics and automation. Mol. J. Biomol. Screen. 16, 134-137
15. Carragher, N. O. et al. (2006) Calpain 2 and Src dependence distinguishes mesenchymal and amoeboid modes of tumour cell invasion: a link to integrin function. Oncogene 25, 5726-5740 (Pubitemid 44435250)
16. Hennigan, R. F. et al. (1994) Fos-transformation activates genes associated with invasion. Oncogene 9, 3591-3600 (Pubitemid 24359397)
17. Wolf, K. et al. (2003) Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J. Cell Biol. 160, 267-277 (Pubitemid 36254960)
18. Sahai, E. and Marshall, C. J. (2003) Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat. Cell Biol. 5, 711-719 (Pubitemid 36986778)
19. Gaggioli, C. et al. (2007) Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat. Cell Biol. 9, 1392-1400 (Pubitemid 350201752)
20. Palermo, C. and Joyce, J. A. (2008) Cysteine cathepsin proteases as pharmacological targets in cancer. Trends Pharmacol. Sci. 29, 22-28
21. Wells, A. et al. (2005) Calpain proteases in cell adhesion and motility. Int. Rev. Cytol. 245, 1-16
22. Carragher, N. O. and Frame, M. C. (2004) Focal adhesion and actin dynamics: a place where kinases and proteases meet to promote invasion. Trends Cell Biol. 14, 241-249 (Pubitemid 38591328)
23. Huttenlocher, A. et al. (1997) Regulation of cell migration by the calciumdependent protease calpain. J. Biol. Chem. 272, 32719-32722 (Pubitemid 28023599)
24. Arguello, F. et al. (1988) A murine model of experimental metastasis to bone and bone marrow. Cancer Res. 48, 6876-6881 (Pubitemid 19012221)
25. Giavazzi, R. et al. (1986) Experimental nude mouse model of human colorectal cancer liver metastases. J. Natl. Cancer Inst. 77, 1303-1308 (Pubitemid 17005109)
26. Iwakawa, M. et al. (1994) A murine model for bone marrow metastasis established by an i.v. injection of C-1300 neuroblastoma in A/J mice. Clin. Exp. Metastasis 12, 231-237 (Pubitemid 24196032)
27. Hoffman, R. M. (1999) Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest. New Drugs 17, 343-359 (Pubitemid 30135902)
28. Khanna, C. and Hunter, K. (2005) Modeling metastasis in vivo. Carcinogenesis 26, 513-523 (Pubitemid 41214139)
29. Fraser, H. (1986) Brain tumours in mice, with particular reference to astrocytoma. Food Chem. Toxicol. 24, 105-111 (Pubitemid 16167135)
30. Huysentruyt, L. C. et al. (2008) Metastatic cancer cells with macrophage properties: evidence from a new murine tumor model. Int. J. Cancer 123, 73-84 (Pubitemid 351705194)
31. Hoffman, R. M. (2009) Imaging cancer dynamics in vivo at the tumor and cellular level with fluorescent proteins. Clin. Exp. Metastasis 26, 345-355
32. Canel, M. et al. (2010) Quantitative in vivo imaging of the effects of inhibiting integrin signaling via Src and FAK on cancer cell movement: effects on E-cadherin dynamics. Cancer Res. 70, 9413-9422
33. Xue, C. et al. (2006) Epidermal growth factor receptor overexpression results in increased tumor cell motility in vivo coordinately with enhanced intravasation and metastasis. Cancer Res. 66, 192-197 (Pubitemid 43166025)
34. Serrels, A. et al. (2009) Real-time study of E-cadherin and membrane dynamics in living animals: implications for disease modeling and drug development. Cancer Res. 69, 2714-2719
35. Timpson, P. et al. (2011) Spatial regulation of RhoA activity during pancreatic cancer cell invasion driven by mutant p53. Cancer Res. 71, 747-757
36. Quaranta, V. et al. (2008) Invasion emerges from cancer cell adaptation to competitive microenvironments: quantitative predictions from multiscale mathematical models. Semin. Cancer Biol. 18, 338-348
37. Zaman, M. H. et al. (2007) Understanding effects of matrix protease and matrix organization on directional persistence and translational speed in three-dimensional cell migration. Ann. Biomed. Eng. 35, 91-100 (Pubitemid 44916318)
38. Bremer, C. et al. (2002) Molecular imaging of MMP expression and therapeutic MMP inhibition. Acad. Radiol. 2 (Suppl.), S314-S315 (Pubitemid 34857705)
39. Shepherd, F. A. et al. (2002) Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J. Clin. Oncol. 20, 4434-4439 (Pubitemid 35334754)
40. Weissleder, R. et al. (1999) In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat. Biotechnol. 17, 375-378 (Pubitemid 29166041)